financetom
Business
financetom
/
Business
/
Trinity Biotech Secures Additional Orders For TrinScreen HIV Rapid Test Product
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trinity Biotech Secures Additional Orders For TrinScreen HIV Rapid Test Product
May 13, 2024 10:51 AM

01:30 PM EDT, 05/13/2024 (MT Newswires) -- Trinity Biotech ( TRIB ) said Monday it secured additional orders for its TrinScreen HIV rapid test product, boosting total orders so far this year to roughly $6 million.

The company said it has ramped up production amid increased demand, adding that it now expects 2024 sales revenue for TrinScreen HIV to be over $8 million.

Shares of the company fell more than 2% in recent trading.

Price: 1.62, Change: -0.04, Percent Change: -2.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved